It is desirable that this different sensitivity of R5broad viruses to CCR5 ligands is further investigated since clinical trials introducing small CCR5 inhibitors for the treatment of pediatric HIV-1 infections are forthcoming. This evidence concerns the gene CCR5 and HIV-1 infection.